Ensysce Biosciences's total assets for Q3 2025 were $3.18M, a decrease of -42.96% from the previous quarter. ENSC total liabilities were $2.30M for the fiscal quarter, a -8.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.